產品中心(xīn)
一抗(kàng)
英文名稱(chēng) Anti-BLVRA/Biliverdin Reductase
中文名稱： 膽(dǎn)綠(lǜ)素還原酶(méi)抗體
別(bié) 名(míng) Biliverdin IX alpha reductase; Biliverdin reductase A; BLVR A; BLVR; BLVRA; BVR A; BVR; BVRA; zinc-metalloprotein; BIEA_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源(yuán) Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域(yù) 細(xì)胞生物(wù) 免疫(yì)學 信號(hào)轉導(dǎo) 激酶和(hé)磷酸(suān)酶(méi) 新陳(chén)代謝
蛋白分(fēn)子(zǐ)量(liáng) predicted molecular weight: 33kDa
性 狀(zhuàng) Lyophilized or Liquid
免 疫 原(yuán) KLH conjugated synthetic peptide derived from human BLVRA/Biliverdin Reductase
亞 型 IgG
純(chún)化方法 affinity purified by Protein A
儲 存 液(yè) Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
產品應用(yòng) WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟(là)切片需做(zuò)抗(kàng)原(yuán)修(xiū)復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保(bǎo)存條(tiáo)件 Store at -20 癈 for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20癈. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 癈.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 In human liver cytosolic fractions, four forms of biliverdin reductase have been identified, including two biliverdin-IX Beta reductases and two biliverdin-IX Alpha reductases, designated isozymes I and II and isozymes III and IV, respectively. Biliverdin reductase A (BLVRA), also designated biliverdin-IX Alpha-reductase, belongs to the GFO/iIDH/MocA family and the biliverdin reductase subfamily. The gene that encodes this cytoplasmic protein maps to chromosome 7p14-cen. BLVRA reduces biliverdin IX (the methene bridge of the open tetrapyrrole) to bilirubin with the concomitant oxidation of an NADH or NADPH cofactor (bilirubin + NADP+ = biliverdin + NADPH). BLVRA is expressed primarily in liver.
Function : Biliverdin Reductase (BVR) catalyzes the final step in the heme metabolic pathway, the reduction of biliverdin IX{alpha} to bilirubin, with the concomitant oxidation of a NADH or NADPH cofactor. The enzyme remains unique among all biological catalysts described to date in having a dual pH/cofactor-dependent activity profile. Human biliverdin reductase (hBVR) has been recently shown to be a Ser/Thr/Tyr kinase in the MAPK insulin/insulin-like growth factor 1 (IGF1)-signaling cascade. BVR together with its substrate, biliverdin, and product, bilirubin, have recently been revealed to be important players in cellular signal transduction pathways, gene expression and oxidative response. These features make BVR unusually interesting and unique among all enzymes characterized to date.
Subunit : Monomer.
Subcellular Location : Cytoplasmic
Tissue Specificity : Liver.
DISEASE : Defects in BLVRA are the cause of hyperbiliverdinemia(HBLVD) [MIM:614156]. HBLVD is a condition characterized by a greendiscoloration of the skin, urine, serum, and other bodily fluids.It is due to increased biliverdin resulting from inefficientconversion to bilirubin. Affected individuals appear to havesymptoms only in the context of obstructive cholestasis and/orliver failure. In some cases, green jaundice can resolve afterresolution of obstructive cholestasis.
Similarity : Belongs to the Gfo/Idh/MocA family. Biliverdinreductase subfamily.
Database links : UniProtKB/Swiss-Prot: P53004.2
中文名稱： 膽(dǎn)綠(lǜ)素還原酶(méi)抗體
別(bié) 名(míng) Biliverdin IX alpha reductase; Biliverdin reductase A; BLVR A; BLVR; BLVRA; BVR A; BVR; BVRA; zinc-metalloprotein; BIEA_HUMAN.
詳細(xì)介紹：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源(yuán) Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域(yù) 細(xì)胞生物(wù) 免疫(yì)學 信號(hào)轉導(dǎo) 激酶和(hé)磷酸(suān)酶(méi) 新陳(chén)代謝
蛋白分(fēn)子(zǐ)量(liáng) predicted molecular weight: 33kDa
性 狀(zhuàng) Lyophilized or Liquid
免 疫 原(yuán) KLH conjugated synthetic peptide derived from human BLVRA/Biliverdin Reductase
亞 型 IgG
純(chún)化方法 affinity purified by Protein A
儲 存 液(yè) Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
產品應用(yòng) WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟(là)切片需做(zuò)抗(kàng)原(yuán)修(xiū)復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保(bǎo)存條(tiáo)件 Store at -20 癈 for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20癈. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 癈.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
相(xiāng)關資(zī)料(liào)：
產品介紹 In human liver cytosolic fractions, four forms of biliverdin reductase have been identified, including two biliverdin-IX Beta reductases and two biliverdin-IX Alpha reductases, designated isozymes I and II and isozymes III and IV, respectively. Biliverdin reductase A (BLVRA), also designated biliverdin-IX Alpha-reductase, belongs to the GFO/iIDH/MocA family and the biliverdin reductase subfamily. The gene that encodes this cytoplasmic protein maps to chromosome 7p14-cen. BLVRA reduces biliverdin IX (the methene bridge of the open tetrapyrrole) to bilirubin with the concomitant oxidation of an NADH or NADPH cofactor (bilirubin + NADP+ = biliverdin + NADPH). BLVRA is expressed primarily in liver.
Function : Biliverdin Reductase (BVR) catalyzes the final step in the heme metabolic pathway, the reduction of biliverdin IX{alpha} to bilirubin, with the concomitant oxidation of a NADH or NADPH cofactor. The enzyme remains unique among all biological catalysts described to date in having a dual pH/cofactor-dependent activity profile. Human biliverdin reductase (hBVR) has been recently shown to be a Ser/Thr/Tyr kinase in the MAPK insulin/insulin-like growth factor 1 (IGF1)-signaling cascade. BVR together with its substrate, biliverdin, and product, bilirubin, have recently been revealed to be important players in cellular signal transduction pathways, gene expression and oxidative response. These features make BVR unusually interesting and unique among all enzymes characterized to date.
Subunit : Monomer.
Subcellular Location : Cytoplasmic
Tissue Specificity : Liver.
DISEASE : Defects in BLVRA are the cause of hyperbiliverdinemia(HBLVD) [MIM:614156]. HBLVD is a condition characterized by a greendiscoloration of the skin, urine, serum, and other bodily fluids.It is due to increased biliverdin resulting from inefficientconversion to bilirubin. Affected individuals appear to havesymptoms only in the context of obstructive cholestasis and/orliver failure. In some cases, green jaundice can resolve afterresolution of obstructive cholestasis.
Similarity : Belongs to the Gfo/Idh/MocA family. Biliverdinreductase subfamily.
Database links : UniProtKB/Swiss-Prot: P53004.2
- 上一條：BIVM蛋白(bái)抗(kàng)體
- 下一條(tiáo)：ARF鳥(niǎo)苷酸交(jiāo)換因子BIG1抗(kàng)體
